Advanced search
Publication Cover
Bioengineered Volume 12, 2021 - Issue 1
Submit an article Journal homepage
1,793
Views
6
CrossRef citations to date
0
Altmetric
Research Paper

Rab18 interacted with V-set and immunoglobulin domain-containing 4 (VSIG4) to involve in the apoptosis of glioma and the sensitivity to temozolomide

Kai YangDepartment of Neurosurgery, The First People’s Hospital of Jinzhong, Jinzhong, ChinaCorrespondence[email protected]
&
Zhi WangDepartment of Neurosurgery, The First People’s Hospital of Jinzhong, Jinzhong, China
Pages 1391-1402 | Received 11 Jan 2021, Accepted 14 Apr 2021, Published online: 27 Apr 2021

References

  • Muller MP, Goody RS. Molecular control of Rab activity by GEFs, GAPs and GDI. Small GTPases. 2018;9:5–21.
  • Ji X, Guo X, Wang Y, et al. Rab18 regulates proliferation, invasion and cisplatin sensitivity through STAT3 signaling in head and neck squamous cell carcinoma. Onco Targets Ther. 2020;13:4123–4134.
  • Wang B, Dong W, Li X. miR-145-5p acts as a novel tumor suppressor in hepatocellular carcinoma through targeting RAB18. Technol Cancer Res Treat. 2019;18. DOI:10.1177/1533033819850189.
  • Wu B, Qi R, Liu X, et al. Rab18 overexpression promotes proliferation and chemoresistance through regulation of mitochondrial function in human gastric cancer. Onco Targets Ther. 2018;11:7805–7820.
  • Liu Q, Tang H, Liu X, et al. miR-200b as a prognostic factor targets multiple members of RAB family in glioma. Med Oncol. 2014;31:859.
  • Vogt L, Schmitz N, Kurrer MO, et al. VSIG4, a B7 family–related protein, is a negative regulator of T cell activation. J Clin Investig. 2006. DOI:10.1172/JCI25673
  • Byun JM, Jeong DH, Choi IH, et al. The significance of VSIG4 expression in ovarian cancer. Int J Gynecol Cancer. 2017;27:872–878.
  • Zhu S, Tan W, Li W, et al. Low expression of VSIG4 is associated with poor prognosis in hepatocellular carcinoma patients with hepatitis B infection. Cancer Manage Res. 2018;10:3697-3705.
  • Liao Y, Guo S, Chen Y, et al. VSIG4 expression on macrophages facilitates lung cancer development. Lab Invest. 2014;94:706.
  • Xu T, Jiang Y, Yan Y, et al. VSIG4 is highly expressed and correlated with poor prognosis of high-grade glioma patients. Am J Transl Res. 2015;7:1172–1180.
  • Zhang XH, Qian Y, Li Z. Let-7g-5p inhibits epithelial-mesenchymal transition consistent with reduction of glioma stem cell phenotypes by targeting VSIG4 in glioblastoma. Oncol Rep. 2016;36:2967–2975.
  • Gong T, Zhou B, Liu M, et al. RAB18 promotes proliferation and metastasis in hepatocellular carcinoma. Am J Transl Res. 2019;11:1009–1019.
  • Lian J, Zou Y, Huang L, et al. Hepatitis B virus upregulates cellular inhibitor of apoptosis protein 2 expression via the PI3K/AKT/NF-kappaB signaling pathway in liver cancer. Oncol Lett. 2020;19:2043–2052.
  • Harris JL, Dave K, Gorman J, et al. The breast cancer antigen 5T4 interacts with Rab11, and is a target and regulator of Rab11 mediated trafficking. Int J Biochem Cell Biol. 2018;99:28–37.
  • Mateus D, Marini ES, Progida C, et al. Rab7a modulates ER stress and ER morphology. Biochim Biophys Acta Mol Cell Res. 2018;1865:781–793.
  • Huang X, Feng Z, Jiang Y, et al. VSIG4 mediates transcriptional inhibition of Nlrp3 and Il-1β in macrophages. Sci Adv. 2019;5:eaau7426.
  • Li J, Diao B, Guo S, et al. VSIG4 inhibits proinflammatory macrophage activation by reprogramming mitochondrial pyruvate metabolism. Nat Commun. 2017;8:1322.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.